Imagine your heart as a vital highway, where blood flows smoothly, fueling your every breath and beat. Now, picture that highway clogged with traffic-dangerous blockages that threaten to bring everything to a standstill. This is what coronary artery disease (CAD) does to your heart. It’s a silent, yet deadly, condition that narrows or blocks the arteries, disrupting the flow of life-giving blood. Left unchecked, CAD can lead to devastating consequences like heart attacks and heart failure, drastically altering the course of your life. But there’s hope-understanding CAD is the first step to keeping your heart’s highway clear and your life on track.
How does genetics impact CAD?
It’s important to understand that CAD is not solely a result of lifestyle factors. Genetics also plays a vital role in its development. It influences key factors like cholesterol levels, blood pressure, and inflammation. Specific genetic variations can lead to high levels of LDL cholesterol, increased susceptibility to hypertension, and chronic inflammation, all of which contribute to the buildup of plaque in the arteries. Additionally, a family history of CAD suggests a higher risk due to shared genetic and lifestyle factors. Understanding these genetic links is crucial for assessing CAD risk and guiding preventive measures.
Why is blood pressure important?
Coronary artery disease (CAD) itself cannot be directly identified solely by blood pressure patterns. However, high blood pressure (hypertension) is a major risk factor for CAD and can contribute to its development. Over time, high blood pressure can damage the arteries, making them more susceptible to plaque buildup, which leads to CAD.
How to manage the risk to live healthily and longer? Let’s take proactive steps.
Hypertension: High blood pressure is a major CAD risk factor, so regular screening is essential, with Ambulatory Blood Pressure Monitoring (ABPM) providing more accurate readings. Early detection and management through lifestyle changes and medical guidance can significantly improve cardiovascular health and reduce CAD risk.
Author
Dr. Anmol S. Kapoor
MD FRCPC
Cardiologist
Founder and CEO, BioAro group of companies
Biongevity, Anryton, CardiAI & MiiCall Technologies
Dr. Anmol S. Kapoor is a visionary Cardiologist, Entrepreneur, and Innovator, leading the charge in the future of longevity medicine through Biongevity. As the founder of BioAro Inc., Dr. Kapoor has been at the forefront of integrating genomics, precision health, and advanced technologies like AI and blockchain into clinical practice. Biongevity aims to redefine healthcare by extending not just lifespan but healthspan, using cutting-edge multi-omics, advanced imaging, and personalized longevity plans. Dr. Kapoor’s commitment to transforming how we manage aging is setting new standards in preventive and longevity medicine, making strides in patient-centered care that targets aging itself rather than just its symptoms.